Sector Update: Health Care Stocks Rise Friday Afternoon

MT Newswires Live

May 17

Health care stocks were higher Friday afternoon, with the NYSE Health Care Index rising 1.5% and the Health Care Select Sector SPDR Fund (XLV) climbing 1.6%.

The iShares Biotechnology ETF (IBB) added 1.3%.

In corporate news, Johnson & Johnson (JNJ) received approval from the UK's Medicines and Healthcare products Regulatory Agency for guselkumab to treat Crohn's disease and ulcerative colitis. The shares rose 1%.

Novo Nordisk (NVO) stock fell 3% after the Danish drugmaker said Chief Executive Officer Lars Fruergaard Jorgensen agreed to step down amid market challenges and share price declines.

BioMarin Pharmaceutical (BMRN) agreed to buy Inozyme Pharma (INZY) for $270 million. Inozyme shares more than doubled, and BioMarin rose 1.9%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2536769346"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2536769346\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2536769346?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-17 01:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2536769346","market":"sh","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Rise Friday Afternoon","media":"MT Newswires Live","content":"<html><body><p> Health care stocks were higher Friday afternoon, with the NYSE Health Care Index rising 1.5% and the Health Care Select Sector SPDR Fund (XLV) climbing 1.6%.</p><p>The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) added 1.3%.</p><p>In corporate news, Johnson &amp; Johnson (JNJ) received approval from the UK's Medicines and Healthcare products Regulatory Agency for guselkumab to treat Crohn's disease and ulcerative colitis. The shares rose 1%.</p><p>Novo Nordisk (NVO) stock fell 3% after the Danish drugmaker said Chief Executive Officer Lars Fruergaard Jorgensen agreed to step down amid market challenges and share price declines.</p><p>BioMarin Pharmaceutical (BMRN) agreed to buy <a href=\"https://laohu8.com/S/INZY\">Inozyme Pharma</a> (INZY) for $270 million. Inozyme shares more than doubled, and BioMarin rose 1.9%.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Rise Friday Afternoon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Rise Friday Afternoon\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-05-17 01:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Health care stocks were higher Friday afternoon, with the NYSE Health Care Index rising 1.5% and the Health Care Select Sector SPDR Fund (XLV) climbing 1.6%.</p><p>The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) added 1.3%.</p><p>In corporate news, Johnson &amp; Johnson (JNJ) received approval from the UK's Medicines and Healthcare products Regulatory Agency for guselkumab to treat Crohn's disease and ulcerative colitis. The shares rose 1%.</p><p>Novo Nordisk (NVO) stock fell 3% after the Danish drugmaker said Chief Executive Officer Lars Fruergaard Jorgensen agreed to step down amid market challenges and share price declines.</p><p>BioMarin Pharmaceutical (BMRN) agreed to buy <a href=\"https://laohu8.com/S/INZY\">Inozyme Pharma</a> (INZY) for $270 million. Inozyme shares more than doubled, and BioMarin rose 1.9%.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BMRN","symbol_name":"拜玛林制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2536769346","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2536769346","pubTimestamp":1747418034,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks were higher Friday afternoon, with the NYSE Health Care Index rising 1.5% and the Health Care Select Sector SPDR Fund  climbing 1.6%.The iShares Biotechnology ETF  added 1.3%.In corporate news, Johnson & Johnson  received approval from the UK's Medicines and Healthcare products Regulatory Agency for guselkumab to treat Crohn's disease and ulcerative colitis. The shares rose 1%.Novo Nordisk  stock fell 3% after the Danish drugmaker said Chief Executive Officer Lars Fruergaard Jorgensen agreed to step down amid market challenges and share price declines.BioMarin Pharmaceutical  agreed to buy Inozyme Pharma  for $270 million. Inozyme shares more than doubled, and BioMarin rose 1.9%.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BMRN":"拜玛林制药","LU2505996681.GBP":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (GBPHDG) INC","BK4559":"巴菲特持仓","LU1732799900.SGD":"JPMorgan Investment Funds - Global Income A (irc) SGD-H","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","LU0889566641.SGD":"FTSF - Templeton Shariah Global Equity A Acc SGD","LU1059921491.USD":"NORDEA 1 GLOBAL STABLE EQUITY \"HB\" (USDHDG) ACC","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","LU2505996509.AUD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (AUDHDG) INC","JNJ":"强生","SG9999002232.USD":"Allianz Global High Payout USD","LU0985320562.USD":"NORDEA 1 GLOBAL STARS EQUITY \"BP\" (USD) ACC","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU1674673428.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AC\" (USD) ACC","LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","SG9999002224.SGD":"Allianz Global High Payout SGD","IE00BVYPNV92.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","IBB":"生物科技指数ETF-iShares Nasdaq","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","LU2347655156.SGD":"JPMorgan Investment Funds - Global Income A (icdiv) SGD-H","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","NVO.AU":"NOVO RESOURCES CORP-CDI","LU1032466523.USD":"高盛全球多资产收益组合Acc","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU0122379950.USD":"贝莱德世界健康科学A2","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","LU2129689431.USD":"FRANKLIN GLOBAL INCOME \"A\" (USD) ACC","LU2592432038.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"A\" (USD) ACC","IE00BVYPNW00.USD":"GUINNESS GLOBAL EQUITY INCOME \"C\" (USD) ACC","IE00BGHQF631.EUR":"GUINNESS GLOBAL EQUITY INCOME \"C\" (EUR) ACC","LU1244550577.SGD":"FTIF - Franklin Global Multi-Asset Income A (Mdis) SGD-H1","XLV":"健康照护类股ETF-SPDR","IE00B3PB1722.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) INC","NVO":"诺和诺德","INZY":"Inozyme Pharma","LU2602419157.SGD":"HSBC ISLAMIC GLOBAL EQUITY INDEX \"AC\" (SGD) ACC","LU0098860793.USD":"FRANKLIN INCOME \"A\" INC","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","SG9999001440.SGD":"United Global Dividend Equity Fund A SGD Dist","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","BK4504":"桥水持仓","LU0345770993.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) INC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H"},"translate_title":"行业更新：医疗保健股周五下午上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVO":0.9,"INZY":0.9,"NVO.AU":1,"IBB":1,"XLV":1,"BMRN":0.9,"JNJ":0.9},"content_text":"Health care stocks were higher Friday afternoon, with the NYSE Health Care Index rising 1.5% and the Health Care Select Sector SPDR Fund (XLV) climbing 1.6%.The iShares Biotechnology ETF (IBB) added 1.3%.In corporate news, Johnson & Johnson (JNJ) received approval from the UK's Medicines and Healthcare products Regulatory Agency for guselkumab to treat Crohn's disease and ulcerative colitis. The shares rose 1%.Novo Nordisk (NVO) stock fell 3% after the Danish drugmaker said Chief Executive Officer Lars Fruergaard Jorgensen agreed to step down amid market challenges and share price declines.BioMarin Pharmaceutical (BMRN) agreed to buy Inozyme Pharma (INZY) for $270 million. Inozyme shares more than doubled, and BioMarin rose 1.9%.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}